Dermoscopic evaluation of efficacy of 308 nm Excimer Laser in treatment of alopecia areata: A prospective study
Keywords:
Alopecia areata, Excimer laser, Dermoscopy, Yellow dots, Short vellus hairsAbstract
Objective To evaluate the therapeutic response of Excimer Laser in treatment of alopecia areata by dermoscopy. Methods A total 34 patches in 24 patients were administered with 308nm excimer laser twice a week for 12 weeks and followed up after 3 months of last sitting. Treatment response was evaluated using regrowth scale (RGS) and dermoscope was used to assess disease activity, response to treatment and side effects. Results Among 34 patches, 4 patches (13%) showed excellent response, 16 patches (47%) showed good response, 7 patches (20%) showed moderate response and 7 patches (20%) showed poor response. Dermoscopically, 27 patches (responders) showed reduction in black dots, yellow dots, broken hairs, tapering hairs and appearance of short vellus hairs which are signs of remitting disease, compared to 7 patches (nonresponders), who showed no change. Yellow dot was the most common dermoscopic finding seen among 85.3% at baseline. Conclusion The excimer laser is one among the efficacious treatment for Alopecia areata. Dermoscopy is useful to assess the response to treatment and side effects.References
Waśkiel‐Burnat A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Alopecia areata predictive score: A new trichoscopy‐based tool to predict treatment outcome in patients with patchy alopecia areata. J Cosmet Dermatol. 2019;00:1–6.
Ganjoo S, Thappa DM. Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata. Indian J Dermatol Venereol Leprol 2013;79:408-17.
Seetharam KA. Alopecia areata: An update. Indian J Dermatol Venereol Leprol 2013;79:563-75.
Byun JW, Moon JH, Bang CY, Shin J, Choi GS. Effectiveness of 308-nm excimer laser therapy in treating alopecia areata, determined by examining the treated sides of selected alopecic patches. Dermatology. 2015;231(1):70-6.
Elnagar RAA, Nada DW, Hassan AM, Hegab DS. Evaluation of the Efficacy of Excimer Light 308 nm Wavelength Versus Low level Laser in Treatment of Alopecia Areata. JAMMR.2021.
Zonunsanga. Comparative study of efficacy of excimer light therapy vs intralesional triamcinolone vs topical 5% minoxidil: an observational study. Our Dermatol Online. 2015;6(1):12-5
Ohtsuki A, Hasegawa T, Komiyama E, Takagi A, Kawasaki J, Ikeda S. 308-nm excimer lamp for the treatment of alopecia areata: Clinical trial on 16 cases. Indian J Dermatol 2013;58:326.
Al Hamzawi NK. Evaluation of the efficacy and safety of 308 nm monochromatic excimer lamp in the treatment of resistant alopecia areata. Int J Trichol 2019;11:199-206.
Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia areata: A multifactorial autoimmune condition. J Autoimmun 2019;98:74 85.
Kranseler JS, Sidbury R. Alopecia areata: Update on management. IndianJ Pediatr Dermatol 2017;18:261 6.
Ghersetich I, Campanile G, Loti T. Alopecia areata: Immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors. Int J Dermatol 1996;35:28 33.
Todes Taylor N, Turner R, Woods GS, Stratte PT, Morhenn VB. T cell subpopulations in alopecia areata. J Am Acad Dermatol 1984;11:216 23.
Ito T. Immune checkpoint inhibitor associated alopecia areata. Br J Dermatol 2017;176:1444 5.
Ramos PM, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, et al. Consensus on the treatment ofalopecia areata --- Brazilian Society of Dermatology. An Bras Dermatol. 2020;95(S1):39-52.
Hegde SP, Naveen KN, Athanikar SB, Reshme P. Clinical and dermatoscopic patterns of alopecia areata: A tertiary care centre experience. Int J Trichol 2013;5:132-6.